Sanders Morris Harris LLC Invests $137,000 in Haleon plc (NYSE:HLN)

Sanders Morris Harris LLC bought a new position in shares of Haleon plc (NYSE:HLN) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 16,700 shares of the company’s stock, valued at approximately $137,000.

Several other large investors have also bought and sold shares of HLN. Ironwood Wealth Management LLC. bought a new position in Haleon in the third quarter valued at approximately $70,000. Tower Research Capital LLC TRC bought a new position in Haleon in the third quarter valued at approximately $115,000. Credit Suisse AG bought a new position in Haleon in the third quarter valued at approximately $76,000. Guggenheim Capital LLC bought a new position in Haleon in the third quarter valued at approximately $119,000. Finally, BlackRock Inc. bought a new position in Haleon in the third quarter valued at approximately $10,366,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Price Performance

Shares of NYSE HLN opened at $8.27 on Friday. The company’s fifty day moving average is $8.37 and its 200-day moving average is $8.37. Haleon plc has a twelve month low of $5.79 and a twelve month high of $9.05. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.84 and a quick ratio of 0.54.

Haleon (NYSE:HLN) last announced its quarterly earnings results on Wednesday, August 2nd. The company reported $0.08 earnings per share for the quarter. The firm had revenue of $3.44 billion for the quarter. On average, equities analysts predict that Haleon plc will post 0.45 earnings per share for the current year.

Haleon Cuts Dividend

The business also recently disclosed a — dividend, which will be paid on Thursday, October 5th. Investors of record on Friday, August 25th will be issued a dividend of $0.046 per share. The ex-dividend date is Thursday, August 24th. This represents a dividend yield of 1.3%.

Analyst Ratings Changes

HLN has been the topic of a number of recent research reports. Investec raised shares of Haleon from a “sell” rating to a “hold” rating in a research note on Tuesday, August 8th. Stifel Nicolaus started coverage on shares of Haleon in a research report on Wednesday, May 24th. They set a “hold” rating on the stock. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $364.00.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.